CLINICAL_TRIALS
trial_result
· 2021-01-27
Clinical Trial Update: Study to Evaluate the Pharmacokinetics of Selonsertib in Participants With Normal and Impaired Hepatic Function [Phase 1]
Summary
Phase 1 pharmacokinetics study evaluating Selonsertib in participants with normal and impaired hepatic function; completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Gilead Sciences | Conditions: Diabetic Kidney Disease | Phase 1 | Status: COMPLETED | Results posted: 2021-01-27